Abstract
The main goal of this study was to analyze, using proteomic techniques, changes in protein expression of acute myeloid leukemia (AML) cells that could give insights into a better early prognosis for tumor pathophysiology. Proteomic analysis of different subtypes of AML cells was carried out using 2-DE and MALDI-TOF PMF analysis. Proteins identified as more significantly altered between the different AMLs belonged to the group of suppressor genes, metabolic enzymes, antioxidants, structural proteins and signal transduction mediators. Among them, seven identified proteins were found significantly altered in almost all the AML blast cells analyzed in relation to normal mononuclear blood cells: alpha-enolase, RhoGDI2, annexin A10, catalase, peroxiredoxin 2, tromomyosin 3, and lipocortin 1 (annexin 1). These differentially expressed proteins are known to play important roles in cellular functions such as glycolysis, tumor suppression, apoptosis, angiogenesis and metastasis, and they might contribute to the adverse evolution of the disease. Proteomic analysis has identified for the first time novel proteins that may either help to form a differential prognosis or be used as markers for disease outcome, thus providing potential new ta...Continue Reading
References
May 1, 1985·Cancer·M Stefanini
Mar 1, 1994·Trends in Pharmacological Sciences·R J Flower, N J Rothwell
Oct 20, 1998·Oncogene·P EsteveJ C Lacal
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L HarrisC D Bloomfield
Dec 23, 1999·The Journal of Biological Chemistry·L C AlldridgeC E Bryant
Mar 4, 2000·Somatic Cell and Molecular Genetics·V ShahG L Prasad
Jul 28, 2001·Seminars in Hematology·A K Burnett
Sep 12, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S L GrazianoJ A Kern
Mar 9, 2002·Molecular and Cellular Biology·Janiel M ShieldsChanning J Der
Apr 18, 2002·Leukemia·J T Lee, J A McCubrey
May 10, 2002·The American Journal of Pathology·Shu-Hsiang LiuHey-Chi Hsu
May 29, 2002·Oncogene·Blanca Scheijen, James D Griffin
Aug 27, 2002·Annual Review of Genomics and Human Genetics·Louise M Kelly, D Gary Gilliland
Sep 12, 2002·Expert Opinion on Therapeutic Targets·Gerhard BehreSheo M Singh
Sep 28, 2002·American Journal of Hematology·Hiroshi FujiwaraChuwa Tei
Aug 19, 2003·Biochimica Et Biophysica Acta·Rob StierumBen van Ommen
Oct 24, 2003·Leukemia·K U BirkenkampE Vellenga
Nov 25, 2003·Hematology·Bob LöwenbergMartin S Tallman
May 5, 2004·Seminars in Oncology·Elliott F Winton, Amelia A Langston
May 15, 2004·Blood·Michael N HarrisXian Chen
Jul 1, 2004·FEBS Letters·Vuokko L KinnulaYlermi Soini
Nov 25, 2004·Hematology·Richard M StoneMikkael A Sekeres
Jan 14, 2005·International Journal of Hematology·Hiroyuki Mano
May 3, 2005·FEBS Letters·Haibin LuoHualiang Jiang
Citations
Aug 17, 2010·Amino Acids·Maria BraoudakiGeorge Th Tsangaris
Nov 13, 2010·Leukemia·E NicolasP Mossuz
Apr 4, 2012·Oncogene·E M GrinerD Theodorescu
Aug 21, 2012·Antioxidants & Redox Signaling·Mary E IrwinJoya Chandra
Nov 3, 2012·Journal of Biomedicine & Biotechnology·Angels Díaz-RamosRoser López-Alemany
Jul 16, 2013·Journal of Hematology & Oncology·Maria BraoudakiFotini Tzortzatou-Stathopoulou
Mar 9, 2010·PloS One·Brady G Miller, John A Stamatoyannopoulos
May 30, 2013·Cellular and Molecular Life Sciences : CMLS·Nina QuiskampUrsula Rescher
Mar 25, 2014·Current Hematologic Malignancy Reports·Bhavana Bhatnagar, Ramiro Garzon
Aug 2, 2012·Journal of Proteomics·Magdalena LuczakMarek Figlerowicz
Apr 10, 2012·Nature Chemical Biology·Chuan-Xu LiuGuo-Qiang Chen
Oct 12, 2010·Leukemia & Lymphoma·Maria BraoudakiFotini Tzortzatou-Stathopoulou
May 16, 2014·Leukemia & Lymphoma·Wenjie JiangYaoqin Gong
Jun 26, 2012·Experimental Cell Research·Chuan-Xu LiuGuo-Qiang Chen
May 12, 2009·Leukemia Research·Yuko IsekiShinichiro Takahashi
Oct 28, 2008·Biochimica Et Biophysica Acta·Fabien RondepierreFrançoise Degoul
Jan 1, 2008·Journal of Biotechnology·Jong Youn BaikGyun Min Lee
Mar 24, 2007·Experimental Hematology·Kanokporn Noy RithidechSanford R Simon
Jan 26, 2011·The FEBS Journal·Michela CapelloFrancesco Novelli
Jun 10, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jung Ho KimGyeong Hoon Kang
Jun 11, 2009·The Biochemical Journal·Fabrizio GentileGiuseppina Barrera
Nov 14, 2013·Journal of Proteomics·Mariasole Di CarliMarcello Donini
Oct 19, 2010·Journal of Oncology·Rémi FiancetteYves Denizot
Apr 23, 2009·Molecular Oncology·Kewal K Jain
Apr 25, 2016·Journal of Proteomics·Elise AasebøMaria Hernandez-Valladares
Sep 15, 2016·Technology in Cancer Research & Treatment·Xin ZhouBing-Dong Zhu
Feb 17, 2017·The Journal of Experimental Medicine·Amelie V GuitartKamil R Kranc
Feb 22, 2018·Cancers·Paola CappelloFrancesco Novelli
May 27, 2006·Leukemia·C López-PedreraF Velasco
Jan 20, 2017·International Journal of Oncology·Hui LingQi Su
Dec 5, 2019·International Journal of Molecular Sciences·Jonathan R SillarMatthew D Dun
Jul 3, 2018·Oncotarget·Anna Li SantiPia Ragno
Jan 22, 2011·Electrophoresis·Jitendra Kumar KanaujiyaArun Kumar Trivedi
Jun 23, 2018·Leukemia·Kim R KampenKim De Keersmaecker
Dec 26, 2018·Oxidative Medicine and Cellular Longevity·Cecilia PrataDiana Fiorentini
Jan 28, 2021·Critical Reviews in Analytical Chemistry·Negin Fasih RamandiHassan Y Aboul-Enein
Mar 7, 2021·International Journal of Molecular Sciences·Silvia TrombettiMichela Grosso
Jul 23, 2008·Journal of Proteome Research·Valeria BertagnoloSilvano Capitani